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Volume 57, Number 5S Abstracts 41Sdespite similar oversizing. Mean angulation changes in the
study group were a -16 6 18 and b -29 6 23.
Conclusions: Severe proximal neck angulation had no
inﬂuence on mid-term results when using the Endurant
endograft. Device conformability resulted in minor
changes in neck angulation over time, possibly reducing
the risk of complications.
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30-day mortality 30-day major morbidit
Odds ratio (P value) Odds ratio (P value)
Prior Stroke NS 2.42 (.019)
ASA Class 4 NS 3.49 (<.001)
Maximal aortic diameter, cm NS NS
Repair type descending-only
hybrid arch hybrid
thoracoabdominal
NS 7.33 (<.001)
4.36 (.021)
NS 2.40 (.006)
3.83 (<.001)
Nonelective status 2.87 (.045) NS
Increasing age 1.05 (.021) NS
Increasing BMI NS NS
ASA, American Society of Anesthesiologists; BMI, body mass index; LOS, lengtPS24.
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Objectives: Frailty has been examined in various popu-
lations as a predictor of morbidity/mortality, but not in
patients undergoing thoracic endovascular aortic repair
(TEVAR). The objective of this study was to evaluate the
role of frailty, as represented by total psoas volume (TPV),
in predicting morbidity & mortality following TEVAR.
Methods: Retrospective analysis was performed on all
patients undergoing TEVAR between 6/2005 and 10/
2012 at a single referral institution. Risk models for 30-day
and 1-year mortality, 30-day major morbidity, and discharge
to a facility were calculated using logistic regression
modeling. Major morbidity was deﬁned as reoperation, pro-
longed mechanical ventilation, acute renal failure, new onset
dialysis, stroke, discharge to a facility, and/or LOS>14 days.
Results: 383 patients were identiﬁed, with 338 (88%)
having data points for all variables used in the ﬁnal model.
Mortality for the cohort at 30 days and 1 year was 7% (n ¼
23) and 19% (n ¼ 62), respectively, while incidence of
major morbidity was 33% (n ¼ 108). TPV was not a statis-
tical signiﬁcant predictor of 30-day or 1-year outcomes.
History of stroke and ASA class 4 were signiﬁcant predic-
tors of all outcomes except 30 day mortality, with which
age, procedure type and nonelective status were statistically
associated (Table).
Conclusions: Frailty, as determined by TPV, does not
predict outcomes in TEVAR. An endovascular approach
may reduce the effect of frailty on morbidity and mortality
following TEVAR.
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Odds ratio (P value) Odds ratio (P value) Odds ratio (P value)
2.35 (.045) 3.42 (.006) 3.07 (.005)
3.04 (.002) 3.58 (.001) 2.17 (.013)
NS NS 1.26 (.016)
NS 7.44 (<.001)
5.05 (<.001)
NS NS NS NS 2.12 (.030) NS
2.88 (.013) NS NS
1.06 (<.001) NS 1.03 (.005)
NS NS 0.93 (.025)
h of stay; NS, nonsigniﬁcant.
